Simulators help industry design better trials

Share this article:

Computers are helping drug companies design smarter clinical trials. The Wall Street Journal reports that manufacturers, such as Pfizer, are using simulators to troubleshoot trial designs and identify potential shortcomings, such as too few patients, before implementation.

The WSJ says the hope is that these programs can cut down on the number of drugs which fail to get regulatory approval due to trial shortcomings, rather than due to issues with the drugs themselves.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.